Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 655

1.

Left Lobe Mobilization Strategy of Right-Sided Major Hepatectomy for Treatment of a Tumor Causing Severe Inferior Vena Cava Compression: A Novel Strategy Using the Modified Liver-Hanging Maneuver.

Araki K, Kubo N, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kuwano H, Shirabe K.

Ann Surg Oncol. 2018 Feb 14. doi: 10.1245/s10434-018-6362-4. [Epub ahead of print]

PMID:
29450751
2.

High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumab.

Bao H, Bai T, Takata K, Yokobori T, Ohnaga T, Hisada T, Maeno T, Bao P, Yoshida T, Kumakura Y, Honjo H, Sakai M, Sohda M, Fukuchi M, Altan B, Handa T, Ide M, Miyazaki T, Ogata K, Oyama T, Shimizu K, Mogi A, Asao T, Shirabe K, Kuwano H, Kaira K.

Oncol Lett. 2018 Mar;15(3):3061-3067. doi: 10.3892/ol.2017.7671. Epub 2017 Dec 20.

3.

Current status of surgical incisions used in donors during living related liver transplantation - a nationwide survey in Japan.

Shirabe K, Eguchi S, Okajima H, Hasegawa K, Marubashi S, Umeshita K, Kawasaki S, Yanaga K, Shimada M, Kaido T, Kawagishi N, Taketomi A, Mizuta K, Kokudo N, Uemoto S, Maehara Y; Japanese Liver Transplantation Society.

Transplantation. 2018 Feb 9. doi: 10.1097/TP.0000000000002126. [Epub ahead of print]

PMID:
29424768
4.

Genetic Analysis of Human Norovirus Strains in Japan in 2016-2017.

Nagasawa K, Matsushima Y, Motoya T, Mizukoshi F, Ueki Y, Sakon N, Murakami K, Shimizu T, Okabe N, Nagata N, Shirabe K, Shinomiya H, Suzuki W, Kuroda M, Sekizuka T, Suzuki Y, Ryo A, Fujita K, Oishi K, Katayama K, Kimura H.

Front Microbiol. 2018 Jan 18;9:1. doi: 10.3389/fmicb.2018.00001. eCollection 2018.

5.

Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers.

Kawaguchi T, Shima T, Mizuno M, Mitsumoto Y, Umemura A, Kanbara Y, Tanaka S, Sumida Y, Yasui K, Takahashi M, Matsuo K, Itoh Y, Tokushige K, Hashimoto E, Kiyosawa K, Kawaguchi M, Itoh H, Uto H, Komorizono Y, Shirabe K, Takami S, Takamura T, Kawanaka M, Yamada R, Matsuda F, Okanoue T.

PLoS One. 2018 Jan 31;13(1):e0185490. doi: 10.1371/journal.pone.0185490. eCollection 2018.

6.

High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer.

Suzuki K, Watanabe A, Araki K, Yokobori T, Harimoto N, Gantumur D, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Kubo N, Gombodorj N, Nishiyama M, Hosouchi Y, Kuwano H, Shirabe K.

Anticancer Res. 2018 Feb;38(2):939-944.

PMID:
29374725
7.

Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1.

Ishii N, Araki K, Yokobori T, Gantumur D, Yamanaka T, Altan B, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Hosouchi Y, Kuwano H, Shirabe K.

Oncotarget. 2017 Nov 6;8(68):112636-112646. doi: 10.18632/oncotarget.22634. eCollection 2017 Dec 22.

8.

Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.

Shirabe K, Bekki Y, Gantumur D, Araki K, Ishii N, Kuno A, Narimatsu H, Mizokami M.

J Gastroenterol. 2018 Jan 9. doi: 10.1007/s00535-017-1425-z. [Epub ahead of print] Review.

PMID:
29318378
9.

Internal Hernia into the Treitz Fossa after Pancreaticoduodenectomy.

Yamanaka T, Araki K, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Kuwano H, Shirabe K.

Case Rep Gastroenterol. 2017 Oct 30;11(3):643-646. doi: 10.1159/000479309. eCollection 2017 Sep-Dec.

10.

Phylogeny and Immunoreactivity of Norovirus GII.P16-GII.2, Japan, Winter 2016-17.

Nagasawa K, Matsushima Y, Motoya T, Mizukoshi F, Ueki Y, Sakon N, Murakami K, Shimizu T, Okabe N, Nagata N, Shirabe K, Shinomiya H, Suzuki W, Kuroda M, Sekizuka T, Ryo A, Fujita K, Oishi K, Katayama K, Kimura H.

Emerg Infect Dis. 2018 Jan;24(1):144-148. doi: 10.3201/eid2401.170284.

11.

Clinical Outcomes of Living Liver Transplantation According to the Presence of Sarcopenia as Defined by Skeletal Muscle Mass, Hand Grip, and Gait Speed.

Harimoto N, Yoshizumi T, Izumi T, Motomura T, Harada N, Itoh S, Ikegami T, Uchiyama H, Soejima Y, Nishie A, Kamishima T, Kusaba R, Shirabe K, Maehara Y.

Transplant Proc. 2017 Nov;49(9):2144-2152. doi: 10.1016/j.transproceed.2017.09.017.

PMID:
29149975
12.

Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma.

Altan B, Kaira K, Watanabe A, Kubo N, Bao P, Dolgormaa G, Bilguun EO, Araki K, Kanai Y, Yokobori T, Oyama T, Nishiyama M, Kuwano H, Shirabe K.

Cancer Chemother Pharmacol. 2018 Jan;81(1):141-153. doi: 10.1007/s00280-017-3477-4. Epub 2017 Nov 17.

PMID:
29149426
13.

Systematic review of the feasibility and future of laparoscopic liver resection for difficult lesions.

Araki K, Kubo N, Watanabe A, Kuwano H, Shirabe K.

Surg Today. 2017 Nov 13. doi: 10.1007/s00595-017-1607-6. [Epub ahead of print] Review.

PMID:
29134500
14.

Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma.

Shiba S, Abe T, Shibuya K, Katoh H, Koyama Y, Shimada H, Kakizaki S, Shirabe K, Kuwano H, Ohno T, Nakano T.

BMC Cancer. 2017 Nov 7;17(1):721. doi: 10.1186/s12885-017-3724-4.

15.

Erratum to: Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial.

Maehara Y, Shirabe K, Kohnoe S, Emi Y, Oki E, Kakeji Y, Baba H, Ikeda M, Kobayashi M, Takayama T, Natsugoe S, Haraguchi M, Yoshida K, Terashima M, Sasako M, Yamaue H, Kokudo N, Uesaka K, Uemoto S, Kosuge T, Sawa Y, Shimada M, Doki Y, Yamamoto M, Taketomi A, Takeuchi M, Akazawa K, Yamanaka T, Shimokawa M.

Surg Today. 2017 Dec;47(12):1539-1540. doi: 10.1007/s00595-017-1589-4.

PMID:
28956067
16.

Risk factors for an additional port in single-incision laparoscopic cholecystectomy in patients with cholecystitis.

Araki K, Shirabe K, Watanabe A, Kubo N, Sasaki S, Suzuki H, Asao T, Kuwano H.

J Med Invest. 2017;64(3.4):245-249. doi: 10.2152/jmi.64.245.

17.

Impact of Splenic Volume and Splenectomy on Prognosis of Hepatocellular Carcinoma Within Milan Criteria After Curative Hepatectomy.

Takeishi K, Kawanaka H, Itoh S, Harimoto N, Ikegami T, Yoshizumi T, Shirabe K, Maehara Y.

World J Surg. 2017 Sep 18. doi: 10.1007/s00268-017-4232-z. [Epub ahead of print]

PMID:
28920178
18.

Small cholangiolocellular carcinoma that was difficult to distinguish from cholangiocellular carcinoma: a case report.

Ishii N, Araki K, Yamanaka T, Handa T, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Aishima S, Kuwano H, Shirabe K.

Surg Case Rep. 2017 Sep 15;3(1):103. doi: 10.1186/s40792-017-0377-0.

19.

Pulmonary inflammation and cytokine dynamics of bronchoalveolar lavage fluid from a mouse model of bronchial asthma during A(H1N1)pdm09 influenza infection.

Fujimoto Y, Hasegawa S, Matsushige T, Wakiguchi H, Nakamura T, Hasegawa H, Nakajima N, Ainai A, Oga A, Itoh H, Shirabe K, Toda S, Atsuta R, Morishima T, Ohga S.

Sci Rep. 2017 Aug 22;7(1):9128. doi: 10.1038/s41598-017-08030-w.

20.

Heat shock-induced HIKESHI protects cell viability via nuclear translocation of heat shock protein 70.

Yanoma T, Ogata K, Yokobori T, Ide M, Mochiki E, Toyomasu Y, Yanai M, Kogure N, Kimura A, Suzuki M, Nakazawa N, Bai T, Oyama T, Asao T, Shirabe K, Kuwano H.

Oncol Rep. 2017 Sep;38(3):1500-1506. doi: 10.3892/or.2017.5844. Epub 2017 Jul 21.

PMID:
28731175

Supplemental Content

Loading ...
Support Center